Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

Autor: Nielsen, Dorte L., Kümler, Iben, Palshof, Jesper A.E., Andersson, Michael
Zdroj: In The Breast February 2013 22(1):1-12
Databáze: ScienceDirect